SYNTHESIS, BENZODIAZEPINE RECEPTOR AFFINITY AND IN-VIVO TESTING OF -ALKYLPYRAZOL-3'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE OR 5'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE
S. Selleri et al., SYNTHESIS, BENZODIAZEPINE RECEPTOR AFFINITY AND IN-VIVO TESTING OF -ALKYLPYRAZOL-3'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE OR 5'-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-ONE, European journal of medicinal chemistry, 32(12), 1997, pp. 941-953
The synthesis of a series of 3-aryl-4,7-dihydro-6-(N-1'-alkylpyrazol-3
or 5'-yl)pyrazolo[1,5-a]pyrimidin-7-ones and their in vitro biologica
l evaluation as ligands for benzodiazepine receptor (BzR) are describe
d. The in vitro activities, as determined by an analysis of GABA (gamm
a-aminobutyric acid) shift ratios, and binding affinities of these com
pounds to BzR are compared in terms of the electronic, lipophilic and
steric effect changes of their substituents either at the 3-position o
r at the N-1' of 6-(pyrazol-3'(5')-yl) moiety. The most interesting co
mpounds were tested in vivo.